Methods and Results. To examine the effects of intracoronary thrombus formation on coronary vasomotor tone of human epicardial arteries in vivo, we studied 15 patients who developed intracoronary thrombi adherent to the guide wire during balloon dilatation. Epicardial artery luminal area was evaluated by quantitative coronary angiography proximal and distal to the site of intracoronary thrombus formation and in a reference vessel before and after thrombus formation as well as after intracoronary injection of 0.2-0.3 mg nitroglycerin. All artery segments distal to the site of thrombus formation showed vasoconstriction with a luminal area reduction of -27.4±17.1% (p<0.001), whereas proximal vessel segments and reference vessels not manipulated during percutaneous transluminal coronary angioplasty did not demonstrate any significant luminal area changes during thrombus formation. Angiographic measurements after advancing the guide wire with the adherent thrombus (performed in six of the 15 patients) revealed in all patients that vasoconstriction did develop at a new site distal to the thrombus with persistence of the initial vasoconstriction now residing proximal to the thrombus. Thus, there was a sequential association between thrombus formation and subsequent distal vasoconstriction. Intracoronary injection of nitroglycerin abolished the thrombus-induced vasoconstriction. No significant luminal area changes were observed in 20 patients without angiographic evidence of intracoronary thrombus formation.
Conclusions. Intracoronary thrombus formation during percutaneous transluminal coronary angioplasty causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Although caution must be advised in the extrapolation of this phenomenon, which was observed in a manipulated artery during coronary angioplasty, the vasoconstrictor response to intracoronary thrombus formation in vivo may play an important role in the dynamic mechanisms of acute coronary heart disease syndromes. large epicardial arteries but also induce marked epicardial vasoconstriction and decreases in coronary blood flow by locally releasing potent vasoconstrictor substances like thromboxane A2 and serotonin.5 6 Moreover, the greatly potentiated vasoconstrictor response to activated platelets reported in atherosclerotic animals with dysfunctional endothelium7,8 has been implicated in the pathogenesis of coronary vasospasm. 9 However, the response of epicardial arterial vasomotor tone to intracoronary platelet aggregation and thrombus formation has never been assessed in the human intact coronary circulation.
The development of angiographically visible intracoronary thrombus formation during percutaneous transluminal coronary angioplasty (PTCA) provides an ideal model to examine the effects of in situ All patients received oral pretreatment with 5 mg isosorbide dinitrate, 10 mg nifedipine, and 330 mg aspirin before PTCA as well as an intravenous injection of 10,000 units heparin at the beginning of the procedure. PTCA was performed by way of the femoral approach using the monorail technique. Balloon sizes were chosen to approximate the diameter of the "normal" coronary segment adjacent to the segment to be dilated. The PTCA procedure followed a standardized protocol, and coronary angiograms were obtained immediately after deflation of the balloon and retraction of the angioplasty catheter into the guiding catheter and also at 5 and 10 minutes after balloon dilatation. If an intraluminal filling defect suggesting the presence of thrombus formation was suspected during the angiogram obtained at 5 or 10 minutes after balloon dilatation, 0.2-0.3 mg nitroglycerin was injected into the coronary system via the guiding catheter, and the angiogram was repeated. In six of the 15 patients, before intracoronary nitroglycerin injection, an additional angiogram suitable for quantitative evaluation was obtained after advancing the guide wire with the adherent thrombus to a more distal position to assess whether vasoconstriction had developed at a new site and to rule out the possibility of passive arterial collapse distal to the thrombus. In the remaining nine patients, the detection of an intraluminal filling defect suggestive of the presence of thrombus formation adherent to the guide wire immediately prompted the intracoronary injection of nitroglycerin to minimize the patient's risk before another coronary angiogram was performed. Thereafter, the PTCA procedure was completed as to obtain an adequate result according to angiographic criteria. In the control patients without angiographic evidence of intracoronary thrombus formation, 0.2-0.3 mg nitroglycerin was injected via the guiding catheter 10 minutes after successful balloon dilatation followed by a final angiogram.
Quantitative Coronary Angiography
Coronary angiography was performed using a simultaneous biplane multidirectional isocentric x-ray system (Siemens Bicor, Erlangen, FRG) at a frame rate of 25 frames/sec with projections that best demonstrated the stenosis to be dilated. End-diastolic cine frames were videodigitized, and quantitative measurements were performed by automatic contour detection as previously described.10-12 In brief, quantitative coronary angiography was performed by automatic contour detectiort using a previously validated geometric edge differentiation technique.10'11 Calculation of the exact radiological magnification factor of the measured segments was used to scale the data from pixels to millimeters as previously described. Table 1 illustrates that there were no significant differences between the two groups with respect to the patient and PTCA procedural data. No patient had a stenosis of greater than 50% diameter reduction after PTCA, indicating that no hemodynamically significant flow obstruction was present during assessment of the coronary vasomotor response to intracoronary thrombus formation. Stenosis severity was reduced by a similar amount in both groups.
There were no significant changes in the hemodynamic parameters of heart rate and blood pressure during intracoronary thrombus formation. Intracoronary nitroglycerin reduced mean blood pressure by -6.1±4.7% in both groups (p<0.01). Coronary Vasomotor Response of Epicardial Arteries Figure 1 illustrates a representative vasoconstrictor response of an obtuse marginal branch of the left circumflex artery during formation of an intracoronary thrombus adherent to the guide wire. In the group of patients with evidence of thrombus formation, mean luminal area of the vessel segment distal to the thrombus was reduced from 4.80±0.61 to 3.59±0.82 mm2 (p<0.01), reflecting a decrease of -27.4±17.1% compared with the prethrombus values (Figure 2 Figure 2) . The proximal and the reference vessel segments did not demonstrate any significant luminal area changes during intracoronary thrombus formation in the thrombus group or at recontrol 10 minutes after successful PTCA in the nonthrombus group ( Figure 3) . However, all segments dilated significantly (p<0.01) in response to intracoronary injection of nitroglycerin (Figure 3 ). There were no significant differences between the analyzed segments and between both groups with respect to the vasodilatory action of intracoronary nitroglycerin.
In the six patients in whom quantitative angiography was available after advancing the guide wire with the adherent thrombus, vasoconstriction developed at a new site, with a luminal area reduction of -21.9+14.1% compared with the first angiogram after thrombus formation. Figure 4 illustrates the development of vasoconstriction at a new site distal to the thrombus with persistence of proximal vasoconstriction after advancement of the guide wire in the left anterior descending artery. Thus, there was a sequential association between thrombus formation and subsequent constriction of arterial segments exposed to the thrombus.
Discussion
The results of the present study demonstrate that intracoronary platelet aggregation and in situ thrombus formation during PTCA may trigger a local vasoconstriction of epicardial arteries in patients with coronary atherosclerosis. This vasoconstriction is maximal immediately distal to the site of thrombus formation, thus suggesting the local re- 
Mechanisms of Thrombus-Induced Vasoconstriction
A recent case-report study13 in patients with acute isehemic heart disease syndromes demonstrated intense microvascular constriction after angioplasty of the presumably thrombotic coronary arterial lesions, thus suggesting the release of vasoconstrictor substances from the clot disrupted by balloon dilatation. The present study is the first to In addition, a number of experimental studies7-9.16-18 have shown that the endothelium plays a critical role in modulating the vessels' response to various vasoactive substances released during thrombus formation like serotonin, thromboxane A2, ADP, and thrombin, with endothelial dysfunction greatly potentiating the vasoconstrictor responses to activated platelets. Thrombin, in addition to being a potent platelet activator itself, has been shown to induce the release of endothelin, a very potent vasoconstrictor peptide.19 Endothelial dysfunction of epicardial arteries is well established in patients with atherosclerosis.11,20'21 Impairment of endogenous endothelial vasodilator mechanisms may thus further contribute to the vasoconstrictor response to intracoronary thrombus formation.
Therefore, it is very likely that the dynamic, focal vasoconstriction of atherosclerotic epicardial arteries in response to intracoronary thrombus formationobserved in the intact coronary circulation of the patients in the present study-results from a combination of the local arterial accumulation of thromboxane A2 and serotonin (and possibly other mediators of vasoconstriction like endothelin) and relative or absolute decreases in local arterial concentrations of endothelium-derived vasodilators, such as endothelium-derived relaxing factors and prostacyclin.
However, it should be kept in mind that the phenomenon of thrombus-induced vasoconstriction was observed in the setting of coronary angioplasty in a manipulated artery. The coronary segment distal to the lesion being dilated may therefore be exposed to minor trauma from guide wire manipulation, which could theoretically induce coronary vasoconstriction due to endothelial injury with secondary platelet aggregation.6,15 This mechanism, however, would not adequately explain the development of vasoconstriction at a new site, which was observed in all patients in whom the thrombus was advanced to a more distal part of the vessel. Thus, the demonstration of a sequential association between thrombus formation and subsequent distal vasoconstriction makes it very unlikely that the observed phenomenon reflects vasoconstriction of a traumatized, hyperreactive vessel segment leading subsequently to proximal thrombus formation. However, we cannot totally exclude the possibility that guide wire trauma may have exacerbated the local constrictor responsiveness of the vessel segments exposed to intracoronary thrombus. Therefore, caution must be exerted to extrapolate the findings of the present study to acute ischemic coronary syndromes.
The development of an intraluminal filling defect adherent to the intracoronary guide wire and remote from the site of balloon dilatation provides unequivocal evidence of intracoronary platelet aggregation and in situ thrombus formation. Although the systemic hemodynamic parameters did not change during the assessment of thrombus-induced vasomotion, thrombus formation might have caused a severe mechanical obstruction leading to a fall in distal arterial distending pressure and resulting in a passive collapse of the arterial lumen distal to the thrombus. However, arterial lumen area was never reduced by more than 70% at the site of thrombus formation during the measurements. In addition, the observed vasoconstriction was a focal localized dynamic process and did not comprise the entire distal vasculature. Most importantly, as illustrated in Figures 1 and 4 Recent studies proposed that epicardial coronary artery vasoconstriction, possibly mediated by endothelium-derived cyclooxygenase products,22 routinely occurs after PTCA not only at the site of balloon dilatation but also distal to this site without angiographic evidence of thrombus formation.23 This angioplasty-induced vasoconstriction could be prevented by intravenous infusion of nitroglycerin.23 In this regard, it is important to note that nitroglycerin given intravenously at physiological concentrations very effectively reduces platelet deposition after deep arterial injury in addition to its direct smooth muscle relaxant effect.15 It is very likely that, although angiographically not detectable, balloon dilatation resulted in platelet deposition and possibly thrombus formation at the site of PTCA in the control group, too. However, the lack of a vasoconstrictor response distal to the site of PTCA in the control group suggests that oral pretreatment with nitrates prevented potential angioplasty-induced vasoconstriction and that platelet deposition was not of sufficient magnitude to induce vasoconstriction of the distal vessel segment. Indeed, Lam et a16 demonstrated a fairly close correlation between the extent of vasoconstriction and the intensity of platelet deposition in damaged porcine arteries after balloon angioplasty.
Clinical Implications
Thrombus-induced vasoconstriction developed despite pretreatment with aspirin, indicating that blocking only the thromboxane A2-dependent pathway of platelet activation completely prevented neither the development of intracoronary thrombi adherent to the guide wire during PTCA nor the thrombusassociated vasoconstriction. Although intracoronary injection of nitroglycerin completely reversed thrombus-associated vasoconstriction, oral pretreatment with nitrates prevented neither the development of intracoronary thrombi nor the thrombus-associated vasoconstriction. Therefore, further studies aiming at a reduction of thrombus-associated vasoconstriction should use more potent, selective inhibitors of plate-let metabolism and activation. Encouraging experimental results have not only been reported for thromboxane and serotonin receptor antagonists5"14 but also for hirudin,24 a potent and specific thrombin inhibitor, and for monoclonal antibodies against platelet membrane receptors. 25 In addition, although caution must be advised in the extrapolation of the findings of the present study, which was limited to patients undergoing coronary angioplasty, the demonstration of focal vasoconstriction of epicardial arteries in response to in situ thrombus formation in the intact coronary circulation may provide further important insights into the dynamic mechanisms of acute coronary heart disease syndromes in humans. Although the degree of arterial luminal area reduction appears to be rather moderate, thrombus-induced vasoconstriction at the site of a coronary arterial lesion may greatly potentiate stenosis severity and may thereby further decrease coronary blood flow and myocardial oxygen delivery.
